Company intelligence / Profile preview
Brinton Pharmaceuticals
Pune, Maharashtra, Indiabrintonhealth.com ↗
- Ownership
- Private
- Employees
- ~667
- Development stage
- Other
01
Overview
Brinton Pharmaceuticals has commercial-stage products and a preclinical-to-market pipeline, with recent focus on innovative dermatology (nanoparticle-based therapies) and infectious disease (favipiravir) programs. Most marketed products target dermatology, paediatrics, and nutrition; pipeline programs are expanding in neurology, orthopaedics, and gynaecology.
- Therapeutic areas
- EndocrinologyMetabolic DisordersInfectious DiseasesDermatologyPulmonologyOther
- Modalities
- Small moleculeNanoparticleBiologicNutraceutical
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
University of Central Lancashire (nanoparticle therapy)Krack Cream/Scholl footcare (strategic consumer health alliance)
Beyond the preview
Go deeper on Brinton Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Brinton Pharmaceuticals.